+

WO1997032593A3 - Composition contenant des iso-flavonoides et des lignanes - Google Patents

Composition contenant des iso-flavonoides et des lignanes Download PDF

Info

Publication number
WO1997032593A3
WO1997032593A3 PCT/GB1997/000622 GB9700622W WO9732593A3 WO 1997032593 A3 WO1997032593 A3 WO 1997032593A3 GB 9700622 W GB9700622 W GB 9700622W WO 9732593 A3 WO9732593 A3 WO 9732593A3
Authority
WO
WIPO (PCT)
Prior art keywords
lignans
flavonoids
composition
component
composition containing
Prior art date
Application number
PCT/GB1997/000622
Other languages
English (en)
Other versions
WO1997032593A2 (fr
Inventor
Michael Stafford Morton
Keith Griffiths
Carl Herman Thoma Adler-Creutz
Original Assignee
Energiser Plc
Michael Stafford Morton
Keith Griffiths
Carl Herman Thoma Adler-Creutz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604945.7A external-priority patent/GB9604945D0/en
Priority claimed from GBGB9610768.5A external-priority patent/GB9610768D0/en
Application filed by Energiser Plc, Michael Stafford Morton, Keith Griffiths, Carl Herman Thoma Adler-Creutz filed Critical Energiser Plc
Priority to AU21009/97A priority Critical patent/AU2100997A/en
Publication of WO1997032593A2 publication Critical patent/WO1997032593A2/fr
Publication of WO1997032593A3 publication Critical patent/WO1997032593A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur une composition et une méthode de traitement servant à combattre certains états morbides, tels que le cancer et spécialement avant que lesdits états ne soient cliniquement détectables, ou alors à un stade peu avancé. Ladite composition a le pouvoir d'élever les niveaux d'iso-flavonoïdes (par exemple la génistéine) et de lignanes (par exemple des entérolactones) du corps à des niveaux d'efficacité thérapeutique. Ladite composition qui se présente sous forme d'aliment sous la forme pratique d'un biscuit ou d'un petit gâteau, comporte un constituant de soja, associé à un constituant de graine de lin, et/ou à un constituant de seigle.
PCT/GB1997/000622 1996-03-08 1997-03-10 Composition contenant des iso-flavonoides et des lignanes WO1997032593A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21009/97A AU2100997A (en) 1996-03-08 1997-03-10 Composition containing iso-flavonoids and lignans

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9604945.7A GB9604945D0 (en) 1996-03-08 1996-03-08 Composition
GB9604945.7 1996-03-08
GB9610768.5 1996-05-23
GBGB9610768.5A GB9610768D0 (en) 1996-05-23 1996-05-23 Composition

Publications (2)

Publication Number Publication Date
WO1997032593A2 WO1997032593A2 (fr) 1997-09-12
WO1997032593A3 true WO1997032593A3 (fr) 1997-10-30

Family

ID=26308892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000622 WO1997032593A2 (fr) 1996-03-08 1997-03-10 Composition contenant des iso-flavonoides et des lignanes

Country Status (2)

Country Link
AU (1) AU2100997A (fr)
WO (1) WO1997032593A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391310B1 (en) 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
EP0954984A1 (fr) * 1998-05-04 1999-11-10 Källna Specialprodukter AB Composition diététique contenant des fibres
US6451849B1 (en) 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
US6689809B2 (en) 1999-03-30 2004-02-10 Hormos Nutraceutical Oy Ltd. Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
FI115192B (fi) * 2001-02-26 2005-03-31 Oriola Oy Funktionaalinen elintarvike ja sen valmistusmenetelmä
FI120901B (fi) * 2004-08-25 2010-04-30 Oriola Oy Funktionaalinen elintarvike ja sen käyttö
JP2008526819A (ja) * 2005-01-10 2008-07-24 ホルモス メディカル リミテッド エストロゲン欠乏に関連する症状を予防または改善するための組成物を製造するためのリグナンの使用
ITPI20110034A1 (it) 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso femminile.
CN108208076A (zh) * 2018-01-09 2018-06-29 广州聚澜健康产业研究院有限公司 一种巧克力舒芙蕾及其制备方法
KR20230055262A (ko) * 2021-10-18 2023-04-25 리누 바이오 헬스 엘티디. 파이토젠을 유효성분으로 포함하는 여성갱년기 질환 예방 및 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (de) * 1990-01-24 1991-07-25 Wilhelm Menge Verfahren zum herstellen einer backware

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (de) * 1990-01-24 1991-07-25 Wilhelm Menge Verfahren zum herstellen einer backware

Also Published As

Publication number Publication date
WO1997032593A2 (fr) 1997-09-12
AU2100997A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
EP1273298A3 (fr) Ritonavir en combinaison avec un inhibiteur de la protéase du VIH additionnel pour le traitement du SIDA
CA2201310A1 (fr) Extraits antineoplasiques de cacao et leurs procedes de preparation et d'utilisation
WO1996005838A3 (fr) Preparation combinee pour le traitement de maladies immunitaires
WO2002056912A3 (fr) Methode de traitement du cancer
CA2301057A1 (fr) Procede permettant d'administrer un taxane liposomal encapsule
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
EP1040827A3 (fr) Utilisation de 3,4-dihydroxy-2-hydroxyméthylepyrrolidine pour le traitement du diabète
AU2176395A (en) Compositions for treatment of diabetic complications
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
WO1997032593A3 (fr) Composition contenant des iso-flavonoides et des lignanes
WO2003005960A3 (fr) Nouveaux cannabinoides bicycliques et tricycliques
CA2373794A1 (fr) Compositions et utilisation d'et743 pour le traitement du cancer
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
WO1996021468A3 (fr) Interferent chimiquement modifie
WO1999009964A3 (fr) Nouvelle composition pharmaceutique
WO1997005870A3 (fr) Emploi de griseofulvine pour inhiber la croissance des cancers
AU2002350115A1 (en) Medical compositions for intravesical treatment of bladder cancer
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
AU2001287850A1 (en) Iron compositions
CA2139385A1 (fr) Produits renfermant une proteine liante de g-csf et de tnf
CA2412789A1 (fr) Compositions destinees a ameliorer la concentration mentale
CA2019812A1 (fr) Nouveau 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones et leur utilisation dans la prevention et le traitement du sida
CA2152771A1 (fr) Derives 7-o-ether de taxane
WO2003045324A3 (fr) 14-methyl-epothilones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1997906264

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWW Wipo information: withdrawn in national office

Ref document number: 1997906264

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97531581

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载